748644
Last Update Posted: 2025-11-20
Recruiting has ended
All Genders accepted | 18 Years-75 Years |
117 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Efficacy Study of Two Treatments in the Remission of Vasculitis
Study of the efficacy of rituximab for maintenance treatment in systemic ANCA-associated vasculitis: prospective, multicenter, controlled, randomized comparative study of rituximab versus azathioprine
Study of the efficacy of rituximab for maintenance treatment in systemic ANCA-associated vasculitis: prospective, multicenter, controlled, randomized comparative study of rituximab versus azathioprine
Eligibility
Relevant conditions:
Wegener Granulomatosis
Microscopic Polyangiitis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov